Shalini Sharp
Direktor/Vorstandsmitglied bei NEUROCRINE BIOSCIENCES, INC.
Vermögen: 136 970 $ am 30.04.2024
Profil
Shalini Sharp is currently the Chairman at Mahzi Therapeutics, Inc. She is also an Independent Director at Neurocrine Biosciences, Inc., Global Alliance for TB Drug Development, Organon & Co., and Dimension Therapeutics, Inc. Ms. Sharp previously served as the Chief Executive Officer at Elan Corp.
Plc and Chief of Staff at Elan Pharmaceuticals LLC.
She was also the Chief Financial Officer & Senior VP-Finance at Ultragenyx Pharmaceutical, Inc. Ms. Sharp has held positions as an Independent Director at Agenus, Inc., Array BioPharma, Inc., Precision BioSciences, Inc., Sutro Biopharma, Inc., and Mirati Therapeutics, Inc. She has an MBA from Harvard Business School and an undergraduate degree from Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.05.2024 | 994 ( 0,00% ) | 136 933 $ | 30.04.2024 | |
ORGANON & CO.
0,00% | 08.04.2024 | 2 ( 0,00% ) | 37 $ | 30.04.2024 |
Aktive Positionen von Shalini Sharp
| Unternehmen | Position | Beginn |
|---|---|---|
| DIMENSION THERAPEUTICS INC | Treasurer | 07.11.2017 |
| NEUROCRINE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 03.02.2020 |
| ORGANON & CO. | Direktor/Vorstandsmitglied | 02.06.2021 |
Alameda County Community Food Bank
 Alameda County Community Food Bank Services to the Health IndustryHealth Services Alameda County Community Food Bank distributes nutritious food to low income county residents. The firm offers hunger and nutrition education programs. It promotes policies to benefit low-income residents. The company was founded in 1985 and is headquartered in Oakland, CA. | Direktor/Vorstandsmitglied | - |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Direktor/Vorstandsmitglied | 13.01.2015 |
Mahzi Therapeutics, Inc.
 Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Vorsitzender | - |
Ehemalige bekannte Positionen von Shalini Sharp
| Unternehmen | Position | Ende |
|---|---|---|
| MIRATI THERAPEUTICS | Direktor/Vorstandsmitglied | 23.01.2024 |
| SUTRO BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 10.04.2023 |
| PRECISION BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 10.05.2022 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Shalini Sharp
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| AGENUS INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| PRECISION BIOSCIENCES, INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Panacea Acquisition Corp. is a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in April 2020 and is headquartered in San Francisco, CA. | Finance |
Alameda County Community Food Bank
Alameda County Community Food Bank Services to the Health IndustryHealth Services Alameda County Community Food Bank distributes nutritious food to low income county residents. The firm offers hunger and nutrition education programs. It promotes policies to benefit low-income residents. The company was founded in 1985 and is headquartered in Oakland, CA. | Health Services |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Health Technology |
